While automated computer identification is possible, our HLA experts perform antibody identification for each patient, taking into consideration sensitization history and the complete clinical picture.
LABS is proficient at various Human Leukocyte Antigen (HLA) typing methods, including sequence-specific primer (SSP), reverse sequence-specific oligonucleotide (RSSO) and sequence-based typing to meet all your histocompatibility needs for both recipients and potential donors. We perform HLA antibody identification for transplant risk assessment. While automated computer identification is possible, our HLA experts perform antibody identification for each patient, taking into consideration sensitization history and the complete clinical picture. We also use HLA antibody identification in the post-transplant clinical setting, which aids in the diagnosis of antibody-mediated rejection.
LABS recognizes that conditions often dictate that our customers require immediate (STAT) test results and information in order to optimize patient management to the best possible outcomes, and our systems are set up to accommodate these requests alongside routine workflow. Flow cytometric crossmatch is performed prior to surgery to assess immunological risk for the patient. Virtual crossmatching services are available to determine histocompatibility between potential recipients and remote donors as this is important when working with Paired Exchange programs and transplant offers outside the local region.
Immunological consultation with transplant teams is one of our strengths, working closely with transplant programs for patient selection, living and deceased donor selection and management of the highly sensitized patient. LABS also screens patients for infectious diseases such as HIV, HBV, HCV, EBV and CMV. Serving the transplantation community since the mid-1980s, LABS delivers accurate test results right when needed to facilitate organ, cord blood and marrow transplantation.